Blackpool Victoria Hospital, known locally as "The Vic", is the main hospital for Blackpool and the Fylde Coast in Lancashire, England. The hospital is managed by the Blackpool Teaching Hospitals NHS Foundation Trust.

There are 767 beds in Blackpool Victoria Hospital.

During the past decade, Blackpool Victoria Hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 16 clinical trials were completed, i.e. on average, 22.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 11 clinical trials were completed. i.e. 44% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blackpool Victoria Hospital" #1 sponsor was "University College, London" with 9 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Celgene" with 4 trials sponsored, "Institute of Cancer Research, United Kingdom" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blackpool Victoria Hospital" #1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "British Heart Foundation" with 4 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Blackpool Victoria Hospital" with 3 trials as a collaborator. Other collaborators include 135 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Blackpool Victoria Hospital" are "Multiple Myeloma" (8 trials), "Coronary Artery Disease" (7 trials), "Heart Failure" (7 trials), "Lymphoma" (6 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Blackpool Victoria Hospital" in a lesser frequency.

Most popular intervention types in "Blackpool Victoria Hospital" are "Drug" (63 trials), "Other" (27 trials), "Device" (18 trials), "Procedure" (18 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Dexamethasone" (7 trials), "cyclophosphamide" (7 trials), "Daratumumab" (6 trials) and "Bortezomib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Blackpool Victoria Hospital" are 105 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Blackpool Victoria Hospital". 1 are not yet recruiting, 28 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Blackpool Victoria Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Blackpool Victoria Hospital, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 23 trials that are defined as “Not Applicable".